Biomea Fusion Crashes 65% After FDA Puts Diabetes Treatment Studies On Hold
Biomea stock crashed Friday after the Food and Drug Administration placed two of the company's diabetes treatment studies on hold, citing concerns of liver toxicity.Please watch the video at Investors ... > react
Open the Full Article - Posted 7 months ago
Latest AR-65 Arkansas News Reports
More results in our AR-65 Arkansas Archives